Prostate Cancer Foundation

Mission statement: PCF funds the world's most promising research to improve the prevention, detection, and treatment of prostate cancer and ultimately save patients' lives. Our goal is to put ourselves out of business, and we will not stop until not another man dies of prostate cancer.

Latest from Prostate Cancer Foundation

Prostate Cancer Foundation Continues its Mission to Protect and Honor U.S. Veterans Diagnosed With Prostate Cancer

November 11, 2021

Article

PCF reinforces its dedication to patient care with pilot nursing program in nearly all 50 states that focuses on genetic services.

Prostate Cancer Foundation Invites Patients to Join the Conversation

October 22, 2021

Article

Each year, Prostate Cancer Foundation researchers come together to discuss the latest developments in the fight against cancer.

The Prostate Cancer Foundation And Actor Harry Lennix Challenge Americans To "Eat It To Beat It" During Prostate Cancer Awareness Month

August 18, 2020

Article

The World's Leading Non-profit Organization in Prostate Cancer Research Encourages Americans to Eat Healthier While Raising Awareness About Health Disparities Among African American Men.

ADT May Offer Some Protection From COVID-19 in Men with Prostate Cancer

June 30, 2020

Article

A PCF-funded study of men with prostate cancer in Italy suggests that men with prostate cancer who were taking ADT were 4 times less likely to be infected with the coronavirus than men who were not on ADT (androgen deprivation therapy), and 5 times less likely to die. These new findings are a game-changer and may lead to potential treatments for COVID-19, even in men without prostate cancer.

Prostate Cancer Foundation's COVID-19 Resources

March 16, 2020

Article

Patients with prostate cancer are facing a unique situation amid the COVID-19 pandemic. Here are some of the resources the Prostate Cancer Foundation is offering to help patients in this turbulent situation.

What You Need to Know About the FDA's Approval of Xtandi in Prostate Cancer

December 22, 2019

Article

Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.